E4J-22366-57083
4 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-27
- 2021-07-14
- 2021-10-13
-
2022-01-05
Dose 3 — Pfizer-BioNTech
-
2022-04-14
Survey response — 12 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: ChildbirthMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-07-06
-
2022-09-27
Dose 4 — Pfizer-BioNTech
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-06
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-12-27
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2022-01-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: Childbirth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release